Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signalling

被引:150
作者
Liechti, Matthias E. [1 ,2 ,3 ]
机构
[1] Univ Hosp, Div Clin Pharmacol & Toxicol, Dept Biomed, Basel, Switzerland
[2] Univ Hosp, Dept Clin Res, Basel, Switzerland
[3] Univ Basel, CH-4003 Basel, Switzerland
基金
瑞士国家科学基金会;
关键词
novel psychoactive substances; designer drugs; amphetamines; research chemicals; pharmacology; toxicology; serotonin; dopamine; CONFIRMED RECREATIONAL USE; CASE-SERIES; SYNTHETIC CANNABINOIDS; MDMA ECSTASY; 3,4-METHYLENEDIOXYPYROVALERONE MDPV; EMERGENCY-DEPARTMENT; CLINICAL TOXICITY; UPTAKE INHIBITORS; LEGAL HIGHS; BATH SALTS;
D O I
10.4414/smw.2015.14043
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Novel psychoactive substances are newly used designer drugs ("internet drugs", "research chemicals", "legal highs") potentially posing similar health risks to classic illicit substances. Chemically, many novel psychoactive substances can be classified as phenethylamines, amphetamines, synthetic cathinones, piperazines, pipradrols/piperidines, aminoindanes benzofurans, and tryptamines. Pharmacologically, these substances interact with various monoaminergic targets. Typically, stimulants inhibit the transport of dopamine and noradrenaline (pipradrols, pyrovalerone cathinones) or induce the release of these monoamines (amphetamines and methamphetamine-like cathinones), entactogens predominantly enhance serotonin release (phenylpiperazines, aminoindanes, para-substituted amphetamines, and MDMA-like cathinones) similar to MDMA (ecstasy), and hallucinogens (tryptamines, hallucinogenic phenethylamines) are direct agonists at serotonergic 5-HT2A receptors. Synthetic cannabinoids are another group of novel substances which all act as agonists at the cannabinoid CB1 receptor similar to THC but are chemically diverse. In particular, the relative serotonergic vs dopaminergic activity (determined by the dopamine/serotonin transporter inhibition ratio in vitro) can be helpful to predict the desired psychotropic but also the toxic effects of novel substances as well as their potential for addiction. Although the use of novel psychoactive substances mostly produces minor or moderate poisonings, serious complications occur. Serotonergic drugs (entactogens and hallucinogens) are associated with acute serotonin syndrome, hyperthermia, seizures, and hyponatremia. Dopaminergic drugs are highly addictive and acute toxicity includes prolonged stimulation, insomnia, agitation, and psychosis. Agitation, anxiety, paranoia, hypertension, and rarely myocardial infarction and renal failure are seen with synthetic cannabinoids. Treatment is supportive.
引用
收藏
页数:12
相关论文
共 85 条
  • [1] The novel recreational drug 3,4-methylenedioxypyrovalerone (MDPV) is a potent psychomotor stimulant: Self-administration and locomotor activity in rats
    Aarde, S. M.
    Huang, P. K.
    Creehan, K. M.
    Dickerson, T. J.
    Taffe, M. A.
    [J]. NEUROPHARMACOLOGY, 2013, 71 : 130 - 140
  • [2] Aarde SA, 2011, NEUROPSYCHOPHARMACOL, V36, pS441
  • [3] [Anonymous], 2014, EUR DRUG REP 2014
  • [4] 'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs?
    Auwaerter, Volker
    Dresen, Sebastian
    Weinmann, Wolfgang
    Mueller, Michael
    Puetz, Michael
    Ferreiros, Nerea
    [J]. JOURNAL OF MASS SPECTROMETRY, 2009, 44 (05): : 832 - 837
  • [5] Fatal brain oedema after ingestion of ecstasy and benzylpiperazine
    Balmelli, C
    Kupferschmidt, H
    Rentsch, K
    Schneemann, M
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2001, 126 (28-29) : 809 - 811
  • [6] Powerful Cocaine-Like Actions of 3,4-Methylenedioxypyrovalerone (MDPV), a Principal Constituent of Psychoactive 'Bath Salts' Products
    Baumann, Michael H.
    Partilla, John S.
    Lehner, Kurt R.
    Thorndike, Eric B.
    Hoffman, Alexander F.
    Holy, Marion
    Rothman, Richard B.
    Goldberg, Steven R.
    Lupica, Carl R.
    Sitte, Harald H.
    Brandt, Simon D.
    Tella, Srihari R.
    Cozzi, Nicholas V.
    Schindler, Charles W.
    [J]. NEUROPSYCHOPHARMACOLOGY, 2013, 38 (04) : 552 - 562
  • [7] AKI Associated with Synthetic Cannabinoids: A Case Series
    Bhanushali, Gautam Kantilal
    Jain, Gaurav
    Fatima, Huma
    Leisch, Leah J.
    Thornley-Brown, Denyse
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2013, 8 (04): : 523 - 526
  • [8] Blough BE, 2014, PSYCHOPHARMACOLOGY B
  • [9] Acute cocaine-related health problems in patients presenting to an urban emergency department in Switzerland: A case series
    Bodmer M.
    Enzler F.
    Liakoni E.
    Bruggisser M.
    Liechti M.E.
    [J]. BMC Research Notes, 7 (1)
  • [10] Hyperthermia and Multiorgan Failure After Abuse of "Bath Salts" Containing 3,4-Methylenedioxypyrovalerone
    Borek, Heather A.
    Holstege, Christopher P.
    [J]. ANNALS OF EMERGENCY MEDICINE, 2012, 60 (01) : 103 - 105